Valuation dashboard for Anteris Technologies Global Corp. (AVR) with P/E N/A, P/B 3.16, EV/EBITDA -5.56 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve.
Analysis Summary
Anteris Technologies Global Corp. reported revenue of $1.9M in the most recent fiscal year, growing at a 5-year CAGR of -18.9%.
Trailing-twelve-month margins: gross margin 37.0%, operating margin -47.4%, net margin -46.2%.
At the current price of $8.16, AVR has negative trailing earnings (P/E not meaningful) and an ROE of -77.66%. Market capitalisation stands at $793M.
Balance sheet quality for AVR: current ratio of 0.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.16 |
| EV / EBITDA | -5.56 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-0.55 |
| vs Current Price | -106.8% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | $793M | 3.16 | -77.7% | |
| ABT | Abbott Laboratories | $177.5B | 33.03 | 3.50 | 10.5% |
| 0Y6X.L | Medtronic Plc | $124.2B | |||
| MDT | Medtronic plc | $117.9B | 22.29 | 2.32 | 10.6% |
| SYK | Stryker Corporation | $105.5B | 27.82 | 4.33 | 16.4% |
| 0R2S.L | Stryker Corporation | $103.6B | 28.10 | 4.37 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $64.5B | 47.43 | 5.68 | 11.9% |
| BSX | Boston Scientific Corporation | $64.4B | 17.49 | 2.57 | 14.9% |
Price
| Price | $8.16 |
| Market Cap | $793M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -77.66% |
| Return on Invested Capital | -41.63% |
| Return on Assets | -38.01% |
| Gross Margin | 36.98% |
| Operating Margin | -4738.36% |
| Net Margin | -4619.67% |
Related companies: ANIK · ARAY · ATLN · CYBN · LNSR · LUCD · MXCT
Explore sector: Healthcare · Medical - Devices
More sections of AVR: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks